Literature DB >> 26183548

French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer.

F Cuny1, E Babin2, J Lacau-Saint-Guily3, B Baujat3, R Bensadoun4, A Bozec5, D Chevalier6, O Choussy7, S Deneuve8, N Fakhry9, J Guigay10, M Makeieff11, J-C Merol11, F Mouawad6, J Pavillet12, C Rebiere13, C Righini14, M-C Sostras15, M Tournaille16, S Vergez17.   

Abstract

Early management in oncology is based on coordination and high-quality exchange between the various health-care partners. The present guidelines are based on a literature search with levels of evidence. Treatment waiting time can be optimized by performing assessment as early as possible (Expert opinion), to limit the interval (ideally, less than 4 weeks) between first consultation and data collection. In the first specialist consultation, diagnostic work-up should be scheduled and the data required for management should be determined (Grade B). Work-up may be conducted on a day-care basis or with conventional admission (Expert opinion). The patient's medico-social context should be taken into account from the outset, with social work involvement whenever necessary (Expert opinion). Pain and nutritional management should be planned for (Grade A) and realistic therapeutic education be provided (Expert opinion). Community-hospital teamwork for supportive care should be optimized (Expert opinion). Management should be early and multidisciplinary, to shorten delay between diagnosis and treatment initiation.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Head and neck cancer; Imaging; Recurrence; Screening; Second location

Mesh:

Year:  2015        PMID: 26183548     DOI: 10.1016/j.anorl.2015.06.007

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  4 in total

1.  Comparison of different guidelines for oral cancer.

Authors:  Hugo Fontan Köhler; Hisham Mehanna; Jatin P Shah; Alvaro Sanabria; Johannes Fagan; Moni A Kuriakose; C Rene Leemans; Brian O'Sullivan; Suren Krishnan; Luiz P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-15       Impact factor: 2.503

2.  What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.

Authors:  Anne-Valerie Guizard; Olivier Dejardin; Ludivine Launay; Simona Bara; Bénédicte Lapôtre-Ledoux; Emmanuel Babin; Guy Launoy; Karine Ligier
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-27       Impact factor: 2.503

3.  Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy.

Authors:  Cédric Chevalier; Aurélie Bertaut; Magali Quivrin; Noémie Vulquin; Cédric Desandes; Mireille Folia; Christian Duvillard; Gilles Truc; Gilles Crehange; Philippe Maingon
Journal:  Clin Transl Radiat Oncol       Date:  2016-12-21

4.  The first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center.

Authors:  T Vanderhaegen; A Pierache; G Mortuaire; B Rysman; R Nicot; D Chevalier; F Mouawad
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2022-04-22       Impact factor: 2.665

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.